D002077Chemicals & DrugsD03.132.577.249.165D03.549.686.165D03.605.497.165D04.615.723.795.165220.998241Butorphanolprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25211175Papoiu ADP, Kraft RA, Coghill RC, Yosipovitch GThe Journal of investigative dermatologyPapoiu ADP, Kraft RA, Coghill RC, Yosipovitch G. Butorphanol suppression of histamine itch is mediated by nucleus accumbens and septal nuclei: a pharmacological fMRI study. J Invest Dermatol. 2015 Feb; 135(2):560-568.J Invest Dermatol2014-09-11T00:00:002014Butorphanol suppression of histamine itch is mediated by nucleus accumbens and septal nuclei: a pharmacological fMRI study.AnesthesiologyWake Forest School of MedicineJamesEisenachJames C. Eisenach MD36.09003100000000-80.26802800000000269Eisenach, JamesProfessorAnthonyAtalaAnthony Atala MD36.08943500000000-80.268632000000003Atala, AnthonyProfessor17721251Lee H, Naughton NN, Woods JH, Ko MCAnesthesiologyLee H, Naughton NN, Woods JH, Ko MC. Effects of butorphanol on morphine-induced itch and analgesia in primates. Anesthesiology. 2007 Sep; 107(3):478-85.Anesthesiology2007-09-01T00:00:002007Effects of butorphanol on morphine-induced itch and analgesia in primates.Urologyhttp://www.wfirm.orgWFIRMtrue1ProfessorProfessortrue1ProfessorProfessor15851889Nelson KE, Eisenach JCAnesthesiologyNelson KE, Eisenach JC. Intravenous butorphanol, meperidine, and their combination relieve pain and distress in women in labor. Anesthesiology. 2005 May; 102(5):1008-13.Anesthesiology2005-05-01T00:00:002005Intravenous butorphanol, meperidine, and their combination relieve pain and distress in women in labor.16488311Dawn AG, Yosipovitch GJournal of the American Academy of DermatologyDawn AG, Yosipovitch G. Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol. 2006 Mar; 54(3):527-31.J Am Acad Dermatol2006-01-18T00:00:002006Butorphanol for treatment of intractable pruritus.18709299Lim GJ, Ishiuji Y, Dawn A, Harrison B, Kim DW, Atala A, Yosipovitch GActa dermato-venereologicaLim GJ, Ishiuji Y, Dawn A, Harrison B, Kim DW, Atala A, Yosipovitch G. In vitro and in vivo characterization of a novel liposomal butorphanol formulation for treatment of pruritus. Acta Derm Venereol. 2008; 88(4):327-30.Acta Derm Venereol2008-01-01T00:00:002008In vitro and in vivo characterization of a novel liposomal butorphanol formulation for treatment of pruritus.0.2706250.08140762research area of0.51880.04171876subject area for